Edesa Biotech
EDSA
33 hedge funds and large institutions have $30M invested in Edesa Biotech in 2026 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 6 closing their positions.
117% more capital invested
Capital invested by funds: $13.8M → $30M (+$16.2M)
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
18% more funds holding
Funds holding: 28 → 33 (+5)
10.56% more ownership
Funds ownership: 31.67% → 42.22% (+11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5.07M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.85M |
| 3 |
BCM
Boxer Capital Management
San Diego,
California
|
+$1.85M |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$319K |
| 5 |
HF
HRT Financial
New York
|
+$284K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$390K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$183K |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$162K |
| 4 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
-$160K |
| 5 |
VF
Virtu Financial
New York
|
-$137K |
EDSA Hedge Fund Activity: Q2 2026 in Review
33 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q2 2026, worth a combined $30M — up 117% from $13.8M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new EDSA positions and 6 closed out — a net gain of 5 holders — while 7 added to existing stakes and 5 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $5.07M. The largest seller was Jane Street, cutting an estimated $390K.
- 33 institutional investors held Edesa Biotech (EDSA) as of Q2 2026, up from 28 in Q1 2026.
- Funds reported $30M of Edesa Biotech stock for Q2 2026, up 117% quarter-over-quarter.
- 11 funds opened new Edesa Biotech positions in Q2 2026 and 6 closed out, a net change of +5 holders.
- The largest Edesa Biotech buyer in Q2 2026 was Millennium Management, an estimated $5.07M added.
- The largest Edesa Biotech seller in Q2 2026 was Jane Street, an estimated $390K sold.
Based on aggregated 13F filings for Q2 2026.